3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Myeloid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Hemorrhage
1
Interventions
fludarabine phosphate
11
Cyclophosphamide
11
Whole-Body Irradiation
8
Mycophenolic Acid
8
Busulfan
7
fludarabine
6
Tacrolimus
6
Peripheral Blood Stem Cell Transplantation
6
Melphalan
5
Rituximab
4
Biopsy
4
Azacitidine
4
venetoclax
3
thymoglobulin
3
apixaban
3
Methotrexate
3
Cyclosporine
3
Antilymphocyte Serum
3
decitabine and cedazuridine drug combination
2
Vorinostat
2
Vancomycin
2
Tretinoin
2
Specimen Handling
2
Sirolimus
2
Lenalidomide
2
Injections
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Etoposide
2
Decitabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
N(4)-oleylcytosine arabinoside
×
Classical hematology
×
90 days
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled